In 2002, the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group reported well-established values for conducting phase II trials for soft-tissue sarcomas. An update is provided for leiomyosarcoma (LMS).

Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas

D'Ambrosio, Lorenzo;
2021

Abstract

In 2002, the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group reported well-established values for conducting phase II trials for soft-tissue sarcomas. An update is provided for leiomyosarcoma (LMS).
Sep 154
253
268
Advanced or metastatic leiomyosarcoma; Benchmark; Efficacy; Meta-analysis; Study design; Benchmarking; Clinical Trials as Topic; Female; Humans; Leiomyosarcoma; Uterine Neoplasms
Kantidakis, Georgios; Litière, Saskia; Neven, Anouk; Vinches, Marie; Judson, Ian; Schöffski, Patrick; Wardelmann, Eva; Stacchiotti, Silvia; D'Ambrosio, Lorenzo; Marréaud, Sandrine; van der Graaf, Winette T A; Kasper, Bernd; Fiocco, Marta; Gelderblom, Hans
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0959804921004007-main.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 3.42 MB
Formato Adobe PDF
3.42 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1869239
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact